April 20, 2021 10:39 AM EDTUpdated 01:30 PM
FDA+
Coronavirus

J&J to restart Covid vac­cine ship­ments to Eu­rope as EMA adds safe­ty warn­ing over rare blood clots

Zachary Brennan

Senior Editor

The Eu­ro­pean Med­i­cines Agency’s safe­ty com­mit­tee on Tues­day rec­om­mend­ed adding a warn­ing to the J&J Covid-19 vac­cine re­gard­ing the rare but some­times fa­tal blood …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times